Concepedia

Magesh Muthu

MM

Statistics

Publications

15

Citations

455

H-Index

13

Active since

2009

Affiliations

John D. Dingell VA Medical Center(Current)

Wayne State University

The Barbara Ann Karmanos Cancer Institute

Michigan United

Florida Agricultural and Mechanical University

Magesh Muthu is an author at John D. Dingell VA Medical Center specializing in molecular oncology, pharmacology, and medicine.

ORCID

Publications per year

2009–2023

15

Publications

15

Ponatinib (AP24534) Is a Novel Potent Inhibitor of Oncogenic RET Mutants Associated With Thyroid Cancer

Valentina De Falco, Preziosa Buonocore, Magesh Muthu et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 95 citations · Full text

, , +17

The β-Catenin Axis Integrates Multiple Signals Downstream from RET/Papillary Thyroid Carcinoma Leading to Cell Proliferation

Maria Domenica Castellone, Valentina De Falco, Deva Magendra Rao et al. · Cancer Research · 2009 · 85 citations · Full text

, , +17

Disulfiram Suppresses Growth of the Malignant Pleural Mesothelioma Cells in Part by Inducing Apoptosis

Vino T. Cheriyan, Ying Wang, Magesh Muthu et al. · PLoS ONE · 2014 · 43 citations · Full text

, , +17

A novel <i>de novo</i> germ‐line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization

Maria Domenica Castellone, Antonella Verrienti, Deva Magendra Rao et al. · Clinical Endocrinology · 2009 · 39 citations

, , +17

A CARP-1 functional mimetic loaded vitamin E-TPGS micellar nano-formulation for inhibition of renal cell carcinoma

Vino T. Cheriyan, Hashem O. Alsaab, Sreeja C. Sekhar et al. · Oncotarget · 2017 · 26 citations · Full text

, , +17

1–5 of 15